Hanna Ritzén, R&D Managing Director at Mercodia shares her thoughts in this interview from Bioanalysis Zone. What are our challenges working with biomarker assays? And what does the future hold for the validation of biomarkers?
In a recent publication, researchers from University of Florida analyzed protein and gene expression levels of diabetes biomarkers within pancreatic tissues from T1D patients. They report the persistence of proinsulin and INS mRNA in pancreata from these patients.
In the second part of the Life Cycle Management series, Hanna Ritzén, Managing Director of R&D, goes through the first step of the Cycle: Design & Development of an Immunoassay.
How does one choose which glucagon assay to use? What is important to think about regarding sensitivity, matrix interference and cross-reactivity?
Glucagon is dysregulated in all forms of diabetes and many of the most efficacious treatments (including bariatric surgery) affect this critical glucose regulator. Read more in our new white paper.
Want to measure GLP-1? What is best, measuring active or total GLP-1? Listen to what Professor Jens Juul Holst has to say about it! In this clip he explains why it's so important to use an assay with high cross-rectivity to GLP-1 (9-36) amide.
Mercodia's Bioanalytical Service provides you with the experience, quality and reliability that are fundamental to a productive partnership. Our experienced team of managers, scientists, technicians and regulatory resources will support you in everything from study design to sample handling. We follow the most recent international guidelines and industry standard white papers for bioanalytical method development and validation.
Our combined expertise will ensure that your studies of PK, PD and biomarkers are performed with the highest possible measurement quality, enabling you to make informed decisions based on accurate bioanalytical data. We are highly flexible in the transfer of data in different formats, to meet individual sponsor needs.
LOOK INSIDE FOR ANSWERS TO THESE QUESTIONS:
Exploring Frontiers in Translational Research
Learn about scientific advances that lead to a better understanding of diseases and therapies. Interviews with scientists and clinicians will provide you with cutting-edge information, coming directly from the source. Explore topics ranging from drug discovery and new FDA regulations to novel approaches to metabolic diseases (e.g., diabetes and heart disease).
At Mercodia, we pride ourselves on providing our customers with quick, accurate support. Below you will find answers to some common questions. If you do not find what you are looking for, please feel free to contact us: contacts
Our professional and experienced Customer Service and Technical Support teams are dedicated to ensuring complete customer satisfaction.